» Articles » PMID: 28195756

Persistence of Zika Virus in Body Fluids - Final Report

Abstract

Background: To estimate the frequency and duration of detectable Zika virus (ZIKV) RNA in human body fluids, we prospectively assessed a cohort of newly infected participants in Puerto Rico.

Methods: We evaluated samples obtained from 150 participants (including 55 men) in whom ZIKV RNA was detected on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay in urine or blood in an enhanced arboviral clinical surveillance site. We collected serum, urine, saliva, semen, and vaginal secretions weekly for the first month and then at 2, 4, and 6 months. All specimens were tested by means of RT-PCR, and serum was tested with the use of anti-ZIKV IgM enzyme-linked immunosorbent assay. Among the participants with ZIKV RNA in any specimen at week 4, biweekly collection continued until all specimens tested negative. We used parametric Weibull regression models to estimate the time until the loss of ZIKV RNA detection in each body fluid and reported the findings in medians and 95th percentiles.

Results: The medians and 95th percentiles for the time until the loss of ZIKV RNA detection were 14 days (95% confidence interval [CI], 11 to 17) and 54 days (95% CI, 43 to 64), respectively, in serum; 8 days (95% CI, 6 to 10) and 39 days (95% CI, 31 to 47) in urine; and 34 days (95% CI, 28 to 41) and 81 days (95% CI, 64 to 98) in semen. Few participants had detectable ZIKV RNA in saliva or vaginal secretions.

Conclusions: The prolonged time until ZIKV RNA clearance in serum in this study may have implications for the diagnosis and prevention of ZIKV infection. Current sexual-prevention guidelines recommend that men use condoms or abstain from sex for 6 months after ZIKV exposure; in 95% of the men in this study, ZIKV RNA was cleared from semen after about 3 months. (Funded by the Centers for Disease Control and Prevention.).

Citing Articles

Robust antiviral innate immune response and miRNA regulatory network were identified in ZIKV-infected cells: implications in the pathogenesis of ZIKV infection.

Lai M, Lai R, He B, Wang X, Chen L, Mo Q Virus Genes. 2025; .

PMID: 39955676 DOI: 10.1007/s11262-025-02136-4.


Recent developments and future directions in point-of-care next-generation CRISPR-based rapid diagnosis.

Hassan Y, Mohamed A, Hassan Y, El-Sayed W Clin Exp Med. 2025; 25(1):33.

PMID: 39789283 PMC: 11717804. DOI: 10.1007/s10238-024-01540-8.


Comparison of the sensitivity and specificity of commercial anti-dengue virus IgG tests to identify persons eligible for dengue vaccination.

Medina F, Vila F, Adams L, Cardona J, Carrion J, Lamirande E J Clin Microbiol. 2024; 62(10):e0059324.

PMID: 39194193 PMC: 11481482. DOI: 10.1128/jcm.00593-24.


[Zika virus infection: sexual transmission and implications for prevention].

Consigny P Med Trop Sante Int. 2024; 4(2).

PMID: 39099710 PMC: 11292433. DOI: 10.48327/mtsi.v4i2.2024.502.


Correlation between viral infections in male semen and infertility: a literature review.

Guo Y, Dong Y, Zheng R, Yan J, Li W, Xu Y Virol J. 2024; 21(1):167.

PMID: 39080728 PMC: 11290048. DOI: 10.1186/s12985-024-02431-w.


References
1.
Perez S, Tato R, Cabrera J, Lopez A, Robles O, Paz E . Confirmed case of Zika virus congenital infection, Spain, March 2016. Euro Surveill. 2016; 21(24). DOI: 10.2807/1560-7917.ES.2016.21.24.30261. View

2.
Busch M, Kleinman S, Tobler L, Kamel H, Norris P, Walsh I . Virus and antibody dynamics in acute west nile virus infection. J Infect Dis. 2008; 198(7):984-93. DOI: 10.1086/591467. View

3.
DOrtenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, Piorkowski G . Evidence of Sexual Transmission of Zika Virus. N Engl J Med. 2016; 374(22):2195-8. DOI: 10.1056/NEJMc1604449. View

4.
Sharp T, Munoz-Jordan J, Perez-Padilla J, Bello-Pagan M, Rivera A, Pastula D . Zika Virus Infection Associated With Severe Thrombocytopenia. Clin Infect Dis. 2016; 63(9):1198-1201. PMC: 5176332. DOI: 10.1093/cid/ciw476. View

5.
Dupont-Rouzeyrol M, Biron A, OConnor O, Huguon E, Descloux E . Infectious Zika viral particles in breastmilk. Lancet. 2016; 387(10023):1051. DOI: 10.1016/S0140-6736(16)00624-3. View